This was the stock's fourth consecutive day of losses.

HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a clinical-stage biopharmaceutical company developing next ...

A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...

According to Benzinga Pro, Gilead Sciences's peer group average for short interest as a percentage of float is 5.13%, which ...

The 26-year-old breakout, aka the Midwest Princess, will take the stage in West Hollywood on March 2. The fundraiser will be co-hosted by Jean Smart, Sheryl Lee Ralph, Neil Patrick Harris and David ...

RBC Capital analyst Brian Abrahams lowered the firm’s price target on Gilead (GILD) to $83 from $84 and keeps a Sector Perform rating on the ...

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...

Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on CytomX Therapeutics (CTMX – Research Report) today and set a price target of ...

The unidentified man is one of 66 confirmed human cases of H5N1 bird flu in the US since 2024, when the current outbreak took ...

Fortunately, my home isn't too far from Stamford Bridge stadium, making it easy to catch the action live! Connect with Peter ...

Traders are still grappling with the prospect of rising trade tensions after Donald Trump denied a report that he might ...

US biopharmaceuticals giant Gilead has thrown its weight behind a potential merger of Ireland’s Poolbeg Pharma and Austria ...